Minerva Ventures Fund added over 0.57% of Sudarshan Pharma Industries and now holds 1.57%, or 39,88,000 shares.
A specialty chemicals manufacturer incorporated in 2008, Sudarshan Pharma Industries produces active pharmaceutical ingredients and finished pharmaceutical formulations for domestic and international markets. The company also engages in the trading of industrial chemicals and solvents. Its integrated operations spanning manufacturing and trading of pharmaceutical and chemical products position it as a diversified player in the specialty chemicals sector.
A Mauritius-based foreign portfolio investor and an active anchor investor in Indian SME public issues, where it has backed a steady run of listings. It also builds positions in listed small caps. The fund reports through more than one vehicle, including an Indus QRAC strategy, and both sit under the same administrator.
